Middle Molecule Find

Rulebook › V-tags › V507

V507 Assessment: anemia

Written V0507 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.80(a)(4) · Appendix H Rev. 246, page 215 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.80(a) Standard: Assessment criteria. The patient’s comprehensive assessment must include, but is not limited to, the following: (4) Evaluation of factors associated with anemia, such as hematocrit, hemoglobin, iron stores, and potential treatment plans for anemia, including administration of erythropoiesis-stimulating agent(s).

Read 42 CFR 494.80 on the eCFR

CMS's interpretive guidance

Interpretive Guidance §494.80(a)(4)

Each patient’s hematologic status must be evaluated for determination of their individual anemia management needs.

Evaluation should address the patient’s anemia, including an assessment of the need for erythropoiesis-stimulating agents (ESA) and/or iron therapy. Evaluation should also address the patient’s volume status, potential for bleeding, infection and other causes of hypo-response.

Citation should not be based solely on the patient’s clinical laboratory results for anemia. Any deficiency for anemia management must be supported by the facility’s lack of identification and assessment of the patient’s hematologic status and/or failure to develop or implement an appropriate plan to help meet the patient’s hematologic needs.

Requirements for the plan of care for anemia management are at V547.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 215 (the full 469-page PDF) before quoting it.

Connected tags

Tags whose guidance points here